EVENT RESOURCES
- Wednesday, September 4, 2024
- Thursday, September 5, 2024
- Friday, September 6, 2024
- Saturday, September 7, 2024
| Name | Time | Virtual Session Link |
|---|---|---|
| Session I: Acute Lymphoblastic Leukemia | 9:00 AM - 11:36 AM | Go To Session |
| Plenary Session I | 12:56 PM - 1:16 PM | Go To Session |
| Session II: Myelodysplastic Syndromes | 1:16 PM - 2:56 PM | Go To Session |
| Session III: Acute Myeloid Leukemia | 3:26 PM - 6:00 PM | Go To Session |
| Name | Time | Virtual Session Link |
|---|---|---|
| Session IV: Chronic Myeloid Leukemia | 8:00 AM - 9:40 AM | Go To Session |
| Session V: MyeloproliferatIVe Neoplasms | 10:10 AM - 11:50 AM | Go To Session |
| Plenary Session II | 1:20 PM - 1:40 PM | Go To Session |
| Session VI: Multiple Myeloma | 1:40 PM - 3:56 PM | Go To Session |
| Session VII: Chronic Lymphocytic Leukemia | 4:26 PM - 6:24 PM | Go To Session |
| Name | Time | Virtual Session Link |
|---|---|---|
| Session VIII: T-Cell Lymphoma | 8:00 AM - 9:40 AM | Go To Session |
| Session IX: Indolent B-Cell Lymphoma | 10:10 AM - 11:42 AM | Go To Session |
| Plenary Session III | 1:07 PM - 1:27 PM | Go To Session |
| Session X: Aggressive B-Cell Lymphoma | 1:27 PM - 3:35 PM | Go To Session |
| Session XI: Mantle Cell Lymphoma | 4:05 PM - 5:17 PM | Go To Session |
| Session XII: Hodgkin Lymphoma | 5:17 PM - 5:53 PM | Go To Session |
| Name | Time | Virtual Session Link |
|---|---|---|
| Session XIII: Cellular therapy | 8:00 AM - 9:01 AM | Go To Session |
| Session XIV: Next Questions | 9:36 AM - 11:56 PM | Go To Session |
Time Zone: (UTC-05:00) Central Time (US & Canada) [Change Time Zone]
Time Zone: (UTC-05:00) Central Time (US & Canada) [Change Time Zone]
Dr. Susan O'Brien MD
University of California, Irvine
Associate Director, Medical Director of the Sue and Ralph Stern Center for Cancer Clinical Trials and Research
University of California, Irvine
Associate Director, Medical Director of the Sue and Ralph Stern Center for Cancer Clinical Trials and Research
MD, PhD Koen Van Besien
UH Seidman Cancer Center
Chief and Director of the Wesley Center for Immunotherapy
UH Seidman Cancer Center
Chief and Director of the Wesley Center for Immunotherapy
Dr. Amin Alousi MD
MD Anderson Cancer Center
Department of Stem Cell Transplantation and Cellular Therapy, Division of Cancer Medicine
MD Anderson Cancer Center
Department of Stem Cell Transplantation and Cellular Therapy, Division of Cancer Medicine
Dr. Jennifer R. Brown MD, PhD
Dana-Farber Cancer Institute
Worthington and Margaret Collette Professor of Medicine in the Field of Hematologic OncologyHarvard Medical SchoolDirector, CLL Center, and Institute Physician
Dana-Farber Cancer Institute
Worthington and Margaret Collette Professor of Medicine in the Field of Hematologic OncologyHarvard Medical SchoolDirector, CLL Center, and Institute Physician
Dr. William Thomas Johnson DO
Memorial Sloan Kettering Cancer Center
Assistant Attending, Lymphoma Service, Cellular Therapy Service, Department of Medicine
Memorial Sloan Kettering Cancer Center
Assistant Attending, Lymphoma Service, Cellular Therapy Service, Department of Medicine
